M
Myomo, Inc. (MYO)
ASE – Real Time Price. Currency in USD
0.78
-0.07 (-8.45%)
At close: May 12, 2026, 4:00 PM EDT
0.80
+0.03 (3.39%)
Pre-market: May 13, 2026, 4:10 AM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
ASE – Real Time Price. Currency in USD
0.78
-0.07 (-8.45%)
At close: May 12, 2026, 4:00 PM EDT
0.80
+0.03 (3.39%)
Pre-market: May 13, 2026, 4:10 AM EDT
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient’s weak or paralyzed arm to enable and improve functional activities of daily living. It also provides MyoPro 2 that includes control technology, configuration software and user interface, and pop-out battery for extended use of the brace; MyoPro2+, which comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device; MyoGames, a virtual training platform; and MyoPro 2x Video Library. In addition, the company offers MyoCare, a post-delivery program that provides follow-up care with clients, therapists, and referral sources; MYOMO; MyoPal; and MyoCoach. Its products are designed to help adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, veteran’s administration, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Burlington, Massachusetts.
| Name | Position |
|---|---|
| Dr. Harry Kovelman M.D. | Chief Medical Officer |
| Mr. Colin Anderson | Global Director of Operations |
| Mr. David A. Henry | Chief Financial Officer |
| Mr. Malcolm G. Bock | Vice President of Engineering & Product Strategy |
| Mr. Micah J. Mitchell | Chief Commercial Officer |
| Mr. Paul R. Gudonis | President, CEO & Chairman |
| Ms. Galina Shtivelman | Senior Director of Human Resources |
| Ms. Kathy Sawyers | Sr. Director of Clinical Outcomes |
| Date | Type | Document |
|---|---|---|
| 2026-05-07 | 8-K | myo-20260507.htm |
| 2026-05-04 | PRE 14A | myo-20260504.htm |
| 2026-04-29 | 10-K/A | myo-20251231.htm |
| 2026-04-16 | 8-K | myo-20260414.htm |
| 2026-03-09 | S-8 | d121692ds8.htm |
| 2026-03-09 | 10-K | myo-20251231.htm |
| 2025-12-16 | 8-K | myo-20251210.htm |
| 2025-11-10 | 8-K | myo-20251104.htm |
| 2025-11-10 | 10-Q | myo-20250930.htm |
| 2025-08-11 | 10-Q | myo-20250630.htm |